NuGen Medical Devices Inc. reported it has completed the delivery and sale of the first 500 units of the Company's needle-free InsuJet injector device and consumables to SC Trustmed SRL ("Trustmed") in Romania as previously announced on June 12th, 2023. The sale, although small in size, was completed earlier than anticipated and represents a milestone for NuGen as first completed bulk B2B sale. The Company estimates a 3 ½ year lifetime value of $450,000 for the sale of the 500 units of InsuJet to Trustmed, the value of the first delivery being $82,000.

The order was received in Second Quarter 2023 and was completed in mid-September with revenue booked and recognized in Third Quarter 2023. The Company anticipates further sales from Trustmed and will report such sales as they occur.